# Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

> **NCT03868254** · — · COMPLETED · sponsor: **Allergan** · enrollment: 174 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** XEN Group
- **PROCEDURE:** Phacoemulsification

## Key facts

- **NCT ID:** NCT03868254
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-05
- **Primary completion:** 2019-10-25
- **Final completion:** 2019-10-25
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868254, "Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03868254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*